Target intelligence / Profile preview

RNA, U6 small nuclear 817, pseudogene (RNU6-817P)

Target
RNU6-817P
Molecular classification
Other, Pseudogene, Non-coding RNA, Small nuclear RNA pseudogene
01

Overview

RNA, U6 small nuclear 817, pseudogene (RNU6-817P) is a human gene classified as a **pseudogene** of the U6 small nuclear RNA (snRNA) family[1][2]. U6 snRNA is a well-studied non-coding RNA component of the spliceosomal machinery, involved in the splicing of pre-mRNA in the nucleus[5]. However, RNU6-817P is specifically a **pseudogene**, meaning it is a non-functional genomic DNA sequence similar to the functional U6 snRNA gene, typically arising by retrotransposon-mediated processes such as LINE-1 (L1) activity[3][8]. Pseudogenes like RNU6-817P do not code for functional RNAs or proteins and generally do not have any direct biological function or established disease associations. RNU6-817P is *not* a therapeutic target, receptor, enzyme, transporter, or transcription factor, but rather a classified pseudogene[1][2][8]. There are *no* known drugs, mechanisms of action, or recognized biomarker roles for RNU6-817P. Its only relevance is as a molecular fossil of ancient retrotransposition activity and may be used as a genomic marker in studies of genome evolution or retrotransposon activity, but this role is not clinical or therapeutic[3][8]. No evidence or data indicates RNU6-817P is involved in any signaling, regulatory, or pathological process.

Other names
RNU6-817PRNA U6 small nuclear 817 pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 817, pseudogene (RNU6-817P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 817, pseudogene (RNU6-817P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call